AzTrials
AzTrials

ContraceptionNCT00829517

Computer-Assisted Provision of Reproductive Health Care

A study testing computer-assisted provision of hormonal contraception and STI module in people with Contraception and Sexually Transmitted Diseases, run by University of Pittsburgh at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project seeks to demonstrate that computer kiosks in a clinic waiting room can improve access to hormonal contraception and screening for sexually transmitted infections. The study will be a randomized controlled trial which will evaluate the use of a computer kiosk module to compare the proportion of women of… Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Contraception, Sexually Transmitted Diseases
What is being tested?
computer-assisted provision of hormonal contraception and STI module
Could I receive a placebo?
No, everyone receives an active treatment
How many people
814 participants
Where
2 sitesUnited States
Study dates
Jan 2011to Nov 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • women who speak English or Spanish who visit a study clinic

Who cannot join

  • women who do not speak English or Spanish

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • UPMC

    Pittsburgh, Pennsylvania, 15213

  • University of California, San Francisco

    San Francisco, California, 94122

Other trials in United States

About this study

This project seeks to demonstrate that computer kiosks in a clinic waiting room can improve access to hormonal contraception and screening for sexually transmitted infections. The study will be a randomized controlled trial which will evaluate the use of a computer kiosk module to compare the proportion of women of reproductive age who receive a prescription for hormonal contraception when computer-assisted provision of hormonal contraception is offered (intervention) to encounters when the study clinic provides standard contraceptive care (control). Subjects will be contacted approximately 3 months (range 2-4 months) after the clinic visit to complete a follow-up phone interview. The study population will include English and Spanish-speaking women ages 18-45 who seek care at this clinic. Our hypothesis is that computer-assisted provision of hormonal contraception (intervention)will increase the proportion of women of reproductive age who receive a prescription for hormonal contraception versus standard contraceptive care(control).

Read the detailed description

Data collection has been completed

Being tested
computer-assisted provision of hormonal contraception, STI module
Keywords
Contraception, sexually transmitted diseases
Medical subject headings
Sexually Transmitted Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • computer-assisted provision of hormonal contraceptionOther

    Also called Family planning kiosk

    a computer program available at a kiosk will offer women information about and a prescription for hormonal contraception that they can ask their clinician to sign.

  • STI moduleOther

    Also called Chlamydia kiosk

    computer module available at a kiosk that will encourage women to be screened for chlamydia

Study groups in NCT00829517
Study groupRoleWhat they receive
STI kioskActive comparatorcomputer-assisted provision of screening for chlamydia
Receives: Other: STI module
contraceptive kioskExperimentalcomputer-assisted provision of hormonal contraception
Receives: Other: computer-assisted provision of hormonal contraception

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. self-reported use of hormonal or more effective contraception

    Measured: 3 months

  2. receipt of screening for sexually transmitted infection

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2009 (estimated)
  2. Study startJan 2011
  3. Primary completionNov 2011
  4. Study completionNov 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
814 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00829517
Sponsor's protocol ID
SFP2-8
Status last verified
Feb 2012
First submitted
23 Jan 2009
Last updated
17 Feb 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing computer-assisted provision of hormonal contraception and STI module in people with Contraception and Sexually Transmitted Diseases, run by University of Pittsburgh at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Feb 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

self-reported use of hormonal or more effective contraception (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in